Optical Coherence Tomography for Classifying and Evaluating Macular Edema, Glaucoma, and Alzheimer's Disease: A Clinical Perspective

Dr. Jagadeesh Kumar, Dr. Susan Daenke

Abstract: Optical Coherence Tomography (OCT) offers a non-invasive, high-resolution method to assess retinal thickness and structural changes in disorders like Macular Edema, Glaucoma, and Alzheimer's Disease. This study explores OCT's ability to classify and evaluate these conditions, providing quantifiable data that enhances clinical management over traditional qualitative methods like angiography. Further, it seeks to accurately classify retinal disorders to enhance disease management and therapeutic outcomes. By analyzing retinal variations with OCT, we aim to improve disease supervision and optimize therapeutic strategies. Our findings, based on trials with nearly 3000 eyes, underscore OCT's potential as a precise tool for diagnosing and monitoring retinal and neurodegenerative diseases. This clinical perspective matters because OCT's ability to detect subtle retinal changes early could transform how we diagnose and treat these widespread, vision-threatening conditions.

Keywords: Optical Coherence Tomography (OCT), Macular Edema, Alzheimer's Disease, Glaucoma, Retinal Disorder Classification

How to Cite?: Dr. Jagadeesh Kumar, Dr. Susan Daenke, "Optical Coherence Tomography for Classifying and Evaluating Macular Edema, Glaucoma, and Alzheimer's Disease: A Clinical Perspective", Volume 14 Issue 3, March 2025, International Journal of Science and Research (IJSR), Pages: 811-819, https://www.ijsr.net/getabstract.php?paperid=SR25316173157, DOI: https://dx.doi.org/10.21275/SR25316173157